Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Assets Average (2016 - 2017)

Historic Assets Average for Tenax Therapeutics (TENX) over the last 5 years, with Q3 2017 value amounting to $12.2 million.

  • Tenax Therapeutics' Assets Average fell 8025.62% to $12.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was $12.2 million, marking a year-over-year decrease of 8025.62%. This contributed to the annual value of $3.7 million for FY2013, which is 365.62% up from last year.
  • Per Tenax Therapeutics' latest filing, its Assets Average stood at $12.2 million for Q3 2017, which was down 8025.62% from $16.3 million recorded in Q2 2017.
  • Tenax Therapeutics' Assets Average's 5-year high stood at $61.9 million during Q3 2016, with a 5-year trough of $3.1 million in Q2 2013.
  • Moreover, its 3-year median value for Assets Average was $16.3 million (2017), whereas its average is $22.8 million.
  • As far as peak fluctuations go, Tenax Therapeutics' Assets Average tumbled by 3692.45% in 2013, and later tumbled by 8025.62% in 2017.
  • Tenax Therapeutics' Assets Average (Quarter) stood at $3.1 million in 2013, then soared by 1234.5% to $41.5 million in 2016, then plummeted by 70.56% to $12.2 million in 2017.
  • Its last three reported values are $12.2 million in Q3 2017, $16.3 million for Q2 2017, and $21.2 million during Q1 2017.